Compare Enveric Biosciences Inc (ENVB) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Oxford Lane Capital Corp — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Oxford Lane Capital Corp trades at $9.35 (market cap $909.61M). The key difference: Oxford Lane Capital Corp is far larger — about 146.7× Enveric Biosciences Inc's market cap, and Oxford Lane Capital Corp pays a 25.76% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | OXLC | |
|---|---|---|
Market Cap | $6.20M | $909.61M |
Sector | Health | Financials |
52-Week High | $17.40 | $18.75 |
52-Week Low | $1.27 | $8.15 |
Enterprise Value | $1.30M | — |
Dividend Yield | — | 25.76% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
